- 全部删除
您的购物车当前为空
Eflucimibe (L0081) 是一种酰基辅酶A:胆固醇酰基转移酶抑制剂,可用于治疗心血管疾病和内分泌与代谢疾病,可用于研究动脉粥样硬化和高脂血症。

Eflucimibe (L0081) 是一种酰基辅酶A:胆固醇酰基转移酶抑制剂,可用于治疗心血管疾病和内分泌与代谢疾病,可用于研究动脉粥样硬化和高脂血症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,270 | In stock | |
| 5 mg | ¥ 2,830 | In stock | |
| 10 mg | ¥ 4,180 | In stock | |
| 25 mg | ¥ 6,530 | In stock | |
| 50 mg | ¥ 8,790 | In stock | |
| 100 mg | ¥ 11,800 | In stock | |
| 200 mg | ¥ 15,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,930 | In stock |
Eflucimibe 相关产品
| 产品描述 | Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia. |
| 别名 | L0081, F-12511 |
| 分子量 | 469.72 |
| 分子式 | C29H43NO2S |
| CAS No. | 202340-45-2 |
| Smiles | [C@H](C(NC1=C(C)C(C)=C(O)C(C)=C1)=O)(SCCCCCCCCCCCC)C2=CC=CC=C2 |
| 密度 | 1.059 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 15 mg/mL (31.93 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容